Search research articles
Contact Us
Filters
Showing results (121-130 of 272) with videos related to
Page
of 28
Sort By:
Kidney International Reports
|
June 9, 2025
The Prevalence and Characteristics of IgA Antibodies to β2-Spectrin and CBX3 in Immunoglobulin A Nephropathy
Ayako Koizumi, Yoshihito Nihei, Kazuaki Mori, et al.
Advances in Therapy
|
September 15, 2021
Efficacy and Cardiovascular Safety of Roxadustat in Dialysis-Dependent Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies
Jonathan Barratt, Wladyslaw Sulowicz, Michael Schömig, et al.
Frontiers in Immunology
|
March 3, 2025
Factor B as a therapeutic target for the treatment of complement-mediated diseases
David Kavanagh, Jonathan Barratt, Anna Schubart, et al.
American Journal of Nephrology
|
October 27, 2015
Intervention Associated Acute Kidney Injury and Long-Term Cardiovascular Outcomes
Athanasios Saratzis, Seamus Harrison, Jonathan Barratt, et al.
Nephron
|
July 30, 2020
Inhibition of the Lectin Pathway of the Complement System as a Novel Approach in the Management of IgA Vasculitis-Associated Nephritis
Haresh Selvaskandan, Chee Kay Cheung, John Dormer, et al.
Diabetes, Obesity & Metabolism
|
May 4, 2023
Effects of atrasentan on markers of liver function in patients with type 2 diabetes and chronic kidney disease
Donald E Kohan, Adrian Liew, Sydney C W Tang, et al.
Kidney International Reports
|
August 13, 2021
A Pilot Study to Predict Risk of IgA Nephropathy Progression Based on miR-204 Expression
Izabella Pawluczyk, Matthew Nicholson, Sean Barbour, et al.
Clinical Kidney Journal
|
June 15, 2026
Measuring effectiveness in immunoglobulin A nephropathy: what are we looking for?
Jonathan Barratt, Jürgen Floege, Richard Lafayette, et al.
Advances in Therapy
|
February 16, 2024
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials
Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, et al.
Kidney International Reports
|
December 22, 2025
Defining Disease Modification in IgA Nephropathy: Toward a Paradigm Shift in Management
Jonathan Barratt, Laura H Mariani, Jai Radhakrishnan, et al.
Page
of 28
Search research articles
Search
Showing results (121-130 of 272) with videos related to
Sort By:
Page
of 28
Kidney International Reports
|
June 9, 2025
The Prevalence and Characteristics of IgA Antibodies to β2-Spectrin and CBX3 in Immunoglobulin A Nephropathy
Ayako Koizumi, Yoshihito Nihei, Kazuaki Mori, et al.
Advances in Therapy
|
September 15, 2021
Efficacy and Cardiovascular Safety of Roxadustat in Dialysis-Dependent Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies
Jonathan Barratt, Wladyslaw Sulowicz, Michael Schömig, et al.
Frontiers in Immunology
|
March 3, 2025
Factor B as a therapeutic target for the treatment of complement-mediated diseases
David Kavanagh, Jonathan Barratt, Anna Schubart, et al.
American Journal of Nephrology
|
October 27, 2015
Intervention Associated Acute Kidney Injury and Long-Term Cardiovascular Outcomes
Athanasios Saratzis, Seamus Harrison, Jonathan Barratt, et al.
Nephron
|
July 30, 2020
Inhibition of the Lectin Pathway of the Complement System as a Novel Approach in the Management of IgA Vasculitis-Associated Nephritis
Haresh Selvaskandan, Chee Kay Cheung, John Dormer, et al.
Diabetes, Obesity & Metabolism
|
May 4, 2023
Effects of atrasentan on markers of liver function in patients with type 2 diabetes and chronic kidney disease
Donald E Kohan, Adrian Liew, Sydney C W Tang, et al.
Kidney International Reports
|
August 13, 2021
A Pilot Study to Predict Risk of IgA Nephropathy Progression Based on miR-204 Expression
Izabella Pawluczyk, Matthew Nicholson, Sean Barbour, et al.
Clinical Kidney Journal
|
June 15, 2026
Measuring effectiveness in immunoglobulin A nephropathy: what are we looking for?
Jonathan Barratt, Jürgen Floege, Richard Lafayette, et al.
Advances in Therapy
|
February 16, 2024
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials
Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, et al.
Kidney International Reports
|
December 22, 2025
Defining Disease Modification in IgA Nephropathy: Toward a Paradigm Shift in Management
Jonathan Barratt, Laura H Mariani, Jai Radhakrishnan, et al.
Page
of 28